FormWeb • levofloxacin

Oregon Department of Corrections

Approved Formulary

QR Code

Add Formweb to your mobile device

Android iOS

February P&T meeting minutes have been posted.

Oregon Department of Corrections

Approved Formulary

Search results for:

levofloxacin

levofloxacin

Formulary Duration Restrictions Limited to 6 weeks without TLC approval.
Cell Status Approved (oral), NFISA (inj)

Brand names: Levaquin

Form	Strength
SOLUTION, INTRAVENOUS	500 mg/100 mL; 750 mg/150 mL
TABLET, ORAL	250 mg; 500 mg; 750 mg

Additional Information:

AUGUST 2013 P&T MINUTES

Last updated: Aug. 23, 2021

Black Box Warning: Tendinitis, tendon rupture
FDA Drug Safety: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research for Levaquin (Levofloxacin) Tablets, Oral Solution and Injection

This site is intended for the staff of Oregon Department of Corrections.
While others may view accessible pages, Oregon Department of Corrections makes no warranty, express or implied,
as to the use of this information outside of Oregon Department of Corrections.

Copyright © 2024 Rpharmy, LLC All Rights Reserved